NMOSD
Clinical trials for NMOSD explained in plain language.
Never miss a new study
Get alerted when new NMOSD trials appear
Sign up with your email to follow new studies for NMOSD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test One-Shot cell therapy to reset the immune system in autoimmune patients
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy called RD06-05 for people with active autoimmune diseases. The therapy involves modifying a patient's own immune cells (CAR-T cells) to target and remove harmful immune cells, aiming to reset the immune system. The main…
Matched conditions: NMOSD
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Real-World watch: tracking a rare neurological disease over five years
Disease control Recruiting nowThis study aims to collect long-term, real-world data on how well specific C5 inhibitor medications control relapses and affect quality of life for adults with AQP4+ NMOSD, a rare autoimmune disorder that attacks the nerves in the eyes and spinal cord. It will follow 122 particip…
Matched conditions: NMOSD
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for kids with rare nerve disease
Disease control Recruiting nowThis study is testing a drug called satralizumab in children aged 2 to 11 who have a rare autoimmune disease called NMOSD, which attacks the nerves in the eyes and spinal cord. The main goal is to see how the drug behaves in children's bodies and to check if it helps prevent dise…
Matched conditions: NMOSD
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC